AbCellera Biologics (ABCL) Shares Outstanding (Entity) (2020 - 2026)
Powered by 
Analysis
AbCellera Biologics (ABCL) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 63.70 Bn | 58.52 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.56 Bn | 52.42 Bn | 52.00 Mn | 399.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 214.24 Mn |
| 6 | BeOne Medicines | 40.16 Bn | 35.06 Bn | 1.53 Bn | 113.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.63 Bn | 32.32 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Royalty Pharma | 28.63 Bn | 27.79 Bn | - | 575.00 Mn |
| 9 | Insmed | 27.73 Bn | 26.57 Bn | 358.27 Mn | 218.28 Mn |
| 10 | AbCellera Biologics | 3.49 Bn | 3.49 Bn | - | 306.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 306.47 Mn |
| Mar 31, 2026 | 303.95 Mn |
| Dec 31, 2025 | 300.60 Mn |
| Sep 30, 2025 | 299.01 Mn |
| Jun 30, 2025 | 295.76 Mn |
| Mar 31, 2025 | 295.76 Mn |
| Dec 31, 2024 | 298.36 Mn |
| Sep 30, 2024 | 290.82 Mn |
| Jun 30, 2024 | 290.82 Mn |
| Mar 31, 2024 | 290.82 Mn |
| Dec 31, 2023 | 293.62 Mn |
| Sep 30, 2023 | 286.85 Mn |
| Jun 30, 2023 | 286.85 Mn |
| Mar 31, 2023 | 286.85 Mn |
| Dec 31, 2022 | 288.43 Mn |
| Sep 30, 2022 | 285.76 Mn |
| Jun 30, 2022 | 285.05 Mn |
| Mar 31, 2022 | 284.52 Mn |
| Dec 31, 2021 | 283.26 Mn |
| Sep 30, 2021 | 281.15 Mn |